141 related articles for article (PubMed ID: 19523464)
41. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
42. Risk stratification for suspected acute coronary syndromes and heart failure in the emergency department.
Peacock WF; Soto-Ruiz KM
Acute Card Care; 2009; 11(3):138-45. PubMed ID: 19452341
[TBL] [Abstract][Full Text] [Related]
43. [Clinical value of monitoring serum cardiac biomarkers in pulmonary thromboembolism-induced myocardial injury].
Hu ZJ; Zhou YQ; Zhang HB; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1853-5. PubMed ID: 18971188
[TBL] [Abstract][Full Text] [Related]
44. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
[TBL] [Abstract][Full Text] [Related]
45. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction.
Kavsak PA; MacRae AR; Lustig V; Bhargava R; Vandersluis R; Palomaki GE; Yerna MJ; Jaffe AS
Am Heart J; 2006 Jul; 152(1):118-25. PubMed ID: 16824840
[TBL] [Abstract][Full Text] [Related]
46. Performance Evaluation of the FREND Cardiac Triple Cartridge on the FREND System.
Lee K; Han M; Song SH; Park KU; Song WH; Song J
Clin Lab; 2016; 62(4):739-42. PubMed ID: 27215097
[TBL] [Abstract][Full Text] [Related]
47. Multicenter evaluation of analytical performance of the Liaison troponin I assay.
Pagani F; Stefini F; Chapelle JP; Lefèvre G; Graïne H; Luthe H; Engelmayer J; Panteghini M
Clin Biochem; 2004 Sep; 37(9):750-7. PubMed ID: 15329312
[TBL] [Abstract][Full Text] [Related]
48. [Redefinition of myocardial infarction--relevance of biomarkers].
Weber M; Hamm C
Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
[TBL] [Abstract][Full Text] [Related]
49. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
50. Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction.
Falahati A; Sharkey SW; Christensen D; McCoy M; Miller EA; Murakami MA; Apple FS
Am Heart J; 1999 Feb; 137(2):332-7. PubMed ID: 9924168
[TBL] [Abstract][Full Text] [Related]
51. Markers of myocardial ischemia in the evaluation of the effect of left anterior descending coronary artery lesion and collateral circulation on myocardial injury in 1-vessel off-pump coronary bypass surgery.
Kirali K; Mansuroğlu D; Kayalar N; Güzelmeriç F; Alp M; Yakut C
Heart Surg Forum; 2003; 6(3):143-8. PubMed ID: 12821428
[TBL] [Abstract][Full Text] [Related]
52. Multi-site, multi-country evaluation of analytical and operational performance of a low-mid volume chemiluminescent immunoassay analyzer.
De Keijzer MH; Perkins S; Motta V; Morelli D; Cristol JP; Dupuy AM; Hong Y; Watanabe S; Waerdt C; Grunewald RW
Clin Lab; 2009; 55(9-10):363-70. PubMed ID: 20099573
[TBL] [Abstract][Full Text] [Related]
53. Multiple biomarker panels for cardiovascular risk assessment.
de Lemos JA; Lloyd-Jones DM
N Engl J Med; 2008 May; 358(20):2172-4. PubMed ID: 18480211
[No Abstract] [Full Text] [Related]
54. Estimating the clinical impact of bringing a multimarker cardiac panel to the bedside in the ED.
Birkhahn RH; Haines E; Wen W; Reddy L; Briggs WM; Datillo PA
Am J Emerg Med; 2011 Mar; 29(3):304-8. PubMed ID: 20825823
[TBL] [Abstract][Full Text] [Related]
55. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction.
Fan J; Ma J; Xia N; Sun L; Li B; Liu H
Clin Lab; 2017 Mar; 63(3):427-433. PubMed ID: 28271683
[TBL] [Abstract][Full Text] [Related]
56. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.
Apple FS; Smith SW; Pearce LA; Murakami MM
Clin Chem; 2009 Jan; 55(1):93-100. PubMed ID: 19028826
[TBL] [Abstract][Full Text] [Related]
57. A multiplexed point-of-care assay for C-reactive protein and N-terminal pro-brain natriuretic peptide.
Melin J; Rundström G; Peterson C; Bakker J; MacCraith BD; Read M; Öhman O; Jönsson C
Anal Biochem; 2011 Feb; 409(1):7-13. PubMed ID: 20875778
[TBL] [Abstract][Full Text] [Related]
58. Analytical performance and clinical decision limit of a new release for cardiac troponin I assay.
Moretti M; Pieretti B; Sisti D; Rocchi M; Gasperoni S
Ann Clin Biochem; 2015 Jan; 52(Pt 1):169-72. PubMed ID: 24711561
[TBL] [Abstract][Full Text] [Related]
59. The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST.
Sato Y; Miyamoto T; Taniguchi R; Nagao K; Matsuoka T; Fukuhara R; Kuwabara Y; Isoda K; Yamane K; Nishi K; Saijyo S; Fujiwara H; Takatsu Y
J Cardiol; 2009 Feb; 53(1):20-7. PubMed ID: 19167634
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Role of Multiple Cardiac Biomarkers in Newly Diagnosed Acute Coronary Syndrome Patients.
Rahman MM; Alam MM; Jahan NA; Shila JS; Arslam MI
Mymensingh Med J; 2016 Apr; 25(2):326-33. PubMed ID: 27277367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
